Lisata Therapeutics Terminates Merger Agreement With Kuva Labs; Termination Due To Kuva Labs' Failure To Obtain Financing, Accept Tendered Shares; Board To Carry Out Strategic Options Including Asset Sale

Benzinga Newsdesk www.benzinga.com Neutral 92.6%

Neg 0% Neu 92.6% Pos 0%

https://www.sec.gov/ix?doc=/Archives/edgar/data/320017/000114036126029541/ef20078724_8k.htm

Comments

No comments yet. Be the first!